End-of-day quote
Other stock markets
|
||
- EUR | - |
Jun. 21 | Qiagen Seeks M&A | CI |
Jun. 21 | Transcript : Qiagen N.V. - Shareholder/Analyst Call |
Chart calendar Qiagen NV
Upcoming events on Qiagen NV
Past events on Qiagen NV
2024-06-26 03:00 am | Stifel European Healthcare Summit |
2024-06-21 04:00 am | Annual General Meeting |
2024-06-17 12:00 pm | Capital Markets Day |
2024-05-22 03:00 am | Deutsche Bank dbAccess European Champions Conference |
2024-05-15 04:00 am | Berenberg MDx Day |
2024-04-30 09:00 am | Q1 2024 Earnings Call |
2024-04-29 04:05 pm | Q1 2024 Earnings Release |
2024-04-04 | American Association for Cancer Research Meeting |
2024-03-26 09:00 am | BNP Exane Healthcare Conference |
2024-03-05 02:10 pm | TD Cowen Health Care Conference |
2024-02-27 03:00 am | UBS European Healthcare Conference |
2024-02-26 03:00 am | Morgan Stanley European MedTech and Life Sciences Conference |
2024-02-07 09:00 am | Q4 2023 Earnings Call |
2024-02-06 04:05 pm | Q4 2023 Earnings Release |
2024-01-29 | Reverse Split: 24.25 of 25 |
2024-01-29 | Capital return instalment |
2024-01-15 10:00 am | German Corporate Conference |
2024-01-12 03:00 am | ODDO BHF Forum |
2024-01-09 09:00 am | Commerzbank and ODDO BHF German Investment Conference |
2024-01-08 04:30 pm | JPMorgan Healthcare Conference |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 1 526 1 526 0.06% | 1 870 1 858 0.68% | 2 252 2 198 2.44% | 2 142 2 139 0.12% | 1 965 1 960 0.26% | 2 001 |
EBITDA Million USD | Released Forecast Spread | 552 532 3.7% | 748 723 3.4% | 884 870 1.67% | 790 791 -0.14% | 659 675 -2.34% | 718 |
EBIT Million USD | Released Forecast Spread | 422 412 2.5% | 627 623 0.57% | 755 714 5.73% | 656 654 0.33% | 529 524 0.88% | 564 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -77,8 -77,9 0.13% | 439 364 20.66% | 626 564 11.04% | 513 538 -4.72% | 430 437 -1.7% | 505 |
Net income Million USD | Released Forecast Spread | -41,5 -29,5 -40.57% | 359 294 22.31% | 513 475 7.83% | 423 424 -0.14% | 341 344 -0.65% | 402 |
EPS USD | Released Forecast Spread | -0,19 -0,11 -62.85% | 1,58 1,30 20.88% | 2,28 2,17 4.8% | 1,90 1,96 -2.99% | 1,48 1,54 -3.96% | 1,81 |
Announcement Date | 04/02/20 | 09/02/21 | 08/02/22 | 10/02/23 | 06/02/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 628 591 6.36% | 516 500 3.15% | 500 482 3.71% | 498 486 2.55% | 485 479 1.41% | 495 493 0.38% | 476 471 1.07% | 509 504 1.01% | 459 457 0.41% | 495 | 504 | 534 | 488 | 523 |
EBITDA Million USD | Released Forecast Spread | 266 240 11.11% | 179 165 8.14% | 176 158 11.2% | 169 164 2.57% | 158 163 -3.31% | 168 194 -13.27% | 158 149 5.95% | 175 175 -0.02% | 153 150 1.93% | 171 | 182 | 200 | 167 | 181 |
EBIT Million USD | Released Forecast Spread | 232 205 13.24% | 146 133 10.33% | 144 129 11.06% | 135 128 5.61% | 124 123 0.65% | 136 134 1.4% | 126 127 -0.37% | 142 139 2.34% | 118 117 0.49% | 135 | 145 | 163 | 131 | 148 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 95,7 94,5 1.29% | |||||||||||||
Net income Million USD | Released Forecast Spread | 155 138 12.44% | 96,7 78,2 23.67% | 82,4 78,1 5.44% | 88,8 73,7 20.58% | 85,0 75,1 13.24% | 80,8 86,1 -6.2% | 77,8 84,7 -8.14% | 97,7 92,3 5.76% | 80,7 76,3 5.79% | 91,8 | 95,7 | 112 | ||
EPS USD | Released Forecast Spread | 0,69 0,62 12.09% | 0,43 0,36 21.29% | 0,37 0,35 6.42% | 0,40 | 0,38 0,33 14.04% | 0,36 0,37 -2.98% | 0,35 0,38 -8.76% | 0,42 0,41 3.43% | 0,36 0,34 6.88% | 0,44 | 0,48 | 0,53 | 0,41 | 0,47 |
Announcement Date | 27/04/22 | 26/07/22 | 07/11/22 | 10/02/23 | 03/05/23 | 08/08/23 | 30/10/23 | 06/02/24 | 29/04/24 | - | - | - | - | - |
2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
2024-07-25 01:00 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
2024-07-26 01:00 am | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Qiagen NV
2024-06-07 02:57 am | POLARIS GROUP: May 2024 Sales and Revenue Release |
2024-05-29 04:01 pm | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
2024-05-23 07:00 am | CUREVAC N.V.: Q1 2024 Earnings Release |
2024-05-22 01:00 am | EVOTEC SE: Q1 2024 Earnings Release |
2024-05-21 05:14 pm | ALVOTECH: Q1 2024 Earnings Release |
2024-05-21 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 am | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
- Stock Market
- Equities
- QGEN Stock
- Stock
- Calendar Qiagen NV